Aarti Drugs Ltd to Hold Board Meeting on July 31, 2026, to Approve Quarterly Financial Results

Aarti Drugs Ltd to Hold Board Meeting on July 31, 2026, to Approve Quarterly Financial Results

Aarti Drugs Ltd to Hold Board Meeting on July 31, 2026, to Approve Quarterly Financial Results​

Aarti Drugs Ltd has scheduled its next Board Meeting of Directors for Friday, July 31, 2026. The meeting is set to consider, approve and take on record the Audited Financial Results for the Quarter ended June 30, 2026.

The company confirmed that following the intimation date of June 26, 2026, the trading window for Aarti Drugs Ltd will remain closed until the expiry of 48 hours after the declaration of the aforementioned financial results.

Aarti Drugs Ltd is a manufacturer of Bulk Drugs and Chemicals. The Board Meeting on July 31, 2026, focuses on finalizing the company's performance metrics for the quarter ending June 30, 2026.

AARTIDRUGS Stock Price Movement​

Shares of Aarti Drugs Limited slipped by 0.49% in post-market trading, settling at ₹404.5 after shedding ₹2.00. The stock traded within a range of ₹401 to ₹410 today, with a total volume of 82,935 shares recorded.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top